Evening injection is an alternative approach
Changes coming to weight loss drug coverage benefits, effective January 1, 2025 Effective January 1, 2025, Independence Blue Cross (IBX) will no longer offer coverage for drugs including glucagon-like peptide-1 receptor antagonist (GLP-1) and non-glucagon-like peptide-1 receptor antagonist (non-GLP-1) indicated for and prescribed solely for weight loss in the absence of other FDA-approved clinical indications
I had somebody come to me saying I'd stopped eating potatoes because I wore a glucose monitor and my blood sugar spiked
Signs of an allergic reaction include severe itching or rash, hives, difficulty breathing or swallowing, lightheadedness, facial flushing, nausea, vomiting, heart palpitations, and swelling of the face, eyes, tongue, or throat
Application: Form: Lyophilized powder for injection
vitamins A, B-complex, and E